Swedish Orphan Biovitrum Balance Sheet Health
Financial Health criteria checks 2/6
Swedish Orphan Biovitrum has a total shareholder equity of SEK35.9B and total debt of SEK18.9B, which brings its debt-to-equity ratio to 52.6%. Its total assets and total liabilities are SEK74.5B and SEK38.6B respectively. Swedish Orphan Biovitrum's EBIT is SEK4.6B making its interest coverage ratio 3.7. It has cash and short-term investments of SEK527.0M.
Key information
52.6%
Debt to equity ratio
kr18.90b
Debt
Interest coverage ratio | 3.7x |
Cash | kr527.00m |
Equity | kr35.90b |
Total liabilities | kr38.62b |
Total assets | kr74.52b |
Recent financial health updates
Swedish Orphan Biovitrum (STO:SOBI) Seems To Use Debt Quite Sensibly
Mar 05Is Swedish Orphan Biovitrum (STO:SOBI) A Risky Investment?
Nov 24Is Swedish Orphan Biovitrum (STO:SOBI) Using Too Much Debt?
Jul 07Is Swedish Orphan Biovitrum (STO:SOBI) A Risky Investment?
Apr 02These 4 Measures Indicate That Swedish Orphan Biovitrum (STO:SOBI) Is Using Debt Reasonably Well
Dec 27Is Swedish Orphan Biovitrum (STO:SOBI) A Risky Investment?
Sep 28Recent updates
Swedish Orphan Biovitrum AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Apr 27Investors Still Waiting For A Pull Back In Swedish Orphan Biovitrum AB (publ) (STO:SOBI)
Apr 24Swedish Orphan Biovitrum AB (publ) Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Apr 06Swedish Orphan Biovitrum (STO:SOBI) Seems To Use Debt Quite Sensibly
Mar 05Swedish Orphan Biovitrum's (STO:SOBI) Weak Earnings May Only Reveal A Part Of The Whole Picture
Feb 15Swedish Orphan Biovitrum AB (publ)'s (STO:SOBI) Earnings Haven't Escaped The Attention Of Investors
Jan 17Is Swedish Orphan Biovitrum (STO:SOBI) A Risky Investment?
Nov 24Is Swedish Orphan Biovitrum (STO:SOBI) Using Too Much Debt?
Jul 07Is Swedish Orphan Biovitrum (STO:SOBI) A Risky Investment?
Apr 02Is Swedish Orphan Biovitrum AB (publ) (STO:SOBI) Trading At A 30% Discount?
Jan 11These 4 Measures Indicate That Swedish Orphan Biovitrum (STO:SOBI) Is Using Debt Reasonably Well
Dec 27Is Swedish Orphan Biovitrum (STO:SOBI) A Risky Investment?
Sep 28Is Swedish Orphan Biovitrum (STO:SOBI) Using Too Much Debt?
Jun 26Swedish Orphan Biovitrum (STO:SOBI) Has A Somewhat Strained Balance Sheet
Mar 28Is Swedish Orphan Biovitrum AB (publ) (STO:SOBI) Trading At A 30% Discount?
Nov 17Is Swedish Orphan Biovitrum (STO:SOBI) A Risky Investment?
Sep 19An Intrinsic Calculation For Swedish Orphan Biovitrum AB (publ) (STO:SOBI) Suggests It's 50% Undervalued
Aug 12Here's Why Swedish Orphan Biovitrum (STO:SOBI) Has A Meaningful Debt Burden
Jun 04Financial Position Analysis
Short Term Liabilities: SOBI's short term assets (SEK12.1B) do not cover its short term liabilities (SEK17.1B).
Long Term Liabilities: SOBI's short term assets (SEK12.1B) do not cover its long term liabilities (SEK21.5B).
Debt to Equity History and Analysis
Debt Level: SOBI's net debt to equity ratio (51.2%) is considered high.
Reducing Debt: SOBI's debt to equity ratio has increased from 41.5% to 52.6% over the past 5 years.
Debt Coverage: SOBI's debt is well covered by operating cash flow (25.1%).
Interest Coverage: SOBI's interest payments on its debt are well covered by EBIT (3.7x coverage).